Growth Metrics

AtriCure (ATRC) Cost of Revenue (2016 - 2025)

AtriCure (ATRC) has disclosed Cost of Revenue for 16 consecutive years, with $35.2 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 11.07% to $35.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $133.7 million through Dec 2025, up 13.56% year-over-year, with the annual reading at $133.7 million for FY2025, 13.56% up from the prior year.
  • Cost of Revenue for Q4 2025 was $35.2 million at AtriCure, up from $32.9 million in the prior quarter.
  • The five-year high for Cost of Revenue was $35.2 million in Q4 2025, with the low at $14.7 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $25.2 million, with a median of $24.2 million recorded in 2023.
  • Peak annual rise in Cost of Revenue hit 31.34% in 2021, while the deepest fall reached 2.75% in 2021.
  • Over 5 years, Cost of Revenue stood at $18.2 million in 2021, then rose by 25.89% to $22.9 million in 2022, then grew by 16.64% to $26.7 million in 2023, then increased by 18.45% to $31.7 million in 2024, then increased by 11.07% to $35.2 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $35.2 million, $32.9 million, and $34.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.